PTPRC and glioblastoma: To determine the expression of CMV in the various glioma specimens, we stained primary GBM specimens with CD11B (a marker of blood cells and macrophages), CD45 (a marker of hematopoietic cells), antibodies against CMV gB glycoprotein and Olig2 (stem cell markers).